Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
7.04M
-
Shares change
-
+1.52M
-
Total reported value, excl. options
-
$42.4M
-
Value change
-
+$9.14M
-
Put/Call ratio
-
1.32
-
Number of buys
-
32
-
Number of sells
-
-21
-
Price
-
$6.03
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q3 2020
82 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q3 2020.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.04M shares
of 78.8M outstanding shares and own 8.93% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.91M shares), Elliott Investment Management L.P. (1.76M shares), STATE STREET CORP (504K shares), GEODE CAPITAL MANAGEMENT, LLC (412K shares), NORTHERN TRUST CORP (338K shares), Cresset Asset Management, LLC (330K shares), Nuveen Asset Management, LLC (134K shares), TWO SIGMA ADVISERS, LP (122K shares), MILLENNIUM MANAGEMENT LLC (107K shares), and BRIDGEWAY CAPITAL MANAGEMENT INC (98.1K shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.